the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

ABMS becomes guide for KSM to enhance governance, tackle bribery risk

KUALA LUMPUR: The Anti-Bribery Management System (ABMS) will be a guide to all departments and agencies under the Ministry of Human Resources (KSM) to strengthen governance and identify the risk of corruption and misuse of power.

Its Minister, Steven Sim Chee Keong said the initiative is now used at the Skills Development Fund Corporation (PTPK) and the move is implemented with the cooperation of the National Institute for Occupational Safety and Health (NIOSH).

“The implementation of ABMS is a proactive measure to ensure PTPK staff abide by the work ethics and show a high level of commitment to eradicate corruption in the civil service.

“The objective is also in line with the framework of Malaysia MADANI, which prioritises integrity and efficiency in public administration,” he said in a statement today.

He said the development of the ABMS was spurred by the excellent performance of the PTPK, which recorded a moderate level of risk through the risk re-rating by the Malaysian Anti-Corruption Commission (MACC) for 2023.

In addition, he said the PTPK, as the main financier of national skills training, remains committed to enhancing the country’s human capital development agenda, especially in technical and vocational education and training (TVET), by providing funding to encourage the community to pursue skills.

He said that the PTPK is constantly aware of and highly committed to ensuring Malaysians enjoy the best services and be a catalyst for change in the 12th Malaysia Plan to improve the TVET ecosystem to develop existing talent. – Bernama

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings